Celltrion Sees Double-Digit Growth In Sales And Profit

As Company’s Biosimilars Strategy Continues To Deliver

 
• By Akriti Seth
  
South Korea Money
South Korea’s Celltrion sees YoY jump in sales on the back of “continued growth of major products” • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products